The strongest association was observed in NAFLD/NASH patients who had a diagnosis of type 2 diabetes—they were more than twice as likely to develop aggressive liver disease. This suggests that diabetes could be a good predictor of liver disease progression. Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of the disease, according to a study led by the Queen Mary University of London and the University of Glasgow.
The study of 18 million people across Europe also suggests that people living with type 2 diabetes are at particular risk of this "silent disease" and should be monitored closely to prevent life-threatening disease progression. Non-alcoholic fatty liver disease (NAFLD) affects up to a quarter of people in the West and is the most common cause of liver disease around the world. It is closely associated with…
